Unlocking Biotech's Future: AI, Atrandi's Innovations, and Generative AI in Drug Discovery
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
Unlocking Biotech's Future: AI, Atrandi's Innovations, and Generative AI in Drug Discovery
-
Narrado por:
-
De:
In this episode, we delve into the transformative power of the data multiplier effect in the biotech sector, as reported by Fierce Biotech. By integrating expertise, monitoring systems, and AI, organizations can enhance the value of data, driving innovation and efficiency. This synergy allows for precise data analysis, improved decision-making, and accelerated R&D processes, crucial for breakthroughs in medical research and patient care.
Next, we highlight Atrandi Biosciences' latest advancements in single-cell analysis, set to be presented at the SLAS2026 International Conference. Their Semi-Permeable Capsule technology and Phyx platform, which uses AI to enrich biological samples, promise to streamline complex workflows and make biological data more accessible to researchers.
Meanwhile, life sciences leaders are embedding AI into their operations, shifting from a competitive advantage to a business necessity. AI is enhancing the identification of key opinion leaders and transforming commercial functions with timely insights, paving the way for future innovations.
Generative AI is revolutionizing drug discovery by designing antibodies for G-protein coupled receptors, crucial in cellular communication. This technology promises to shorten discovery timelines and improve success rates across various conditions, though further advancements are needed.
Finally, a Google Cloud survey reveals that AI is increasingly used in life sciences and healthcare for marketing, tech support, and productivity, with significant returns on investment. Despite regulatory challenges, AI is transforming drug development, emphasizing trust and traceability in its applications.
Join Stan Berteloot, a French-American journalist and AI expert, as he navigates these cutting-edge developments in the biotech and life sciences sectors.
Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture.
As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics.
Start your VoiceStream free trial today!
Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today!